A solid-phase extraction and size-exclusion liquid chromatographic method for polyethylene glycol 25 p-aminobenzoic acid determination in urine: validation for urinary excretion studies of users of sunscreens

No previous publications about percutaneous absorption of polyethylene glycol 25 p-aminobenzoic acid (PEG-25 PABA) have been found in the literature and the expected levels to be found in human urine after sunscreens use are unknown. The method proposed here is suitable to determine PEG-25 PABA in the urine of sunscreens users in order to carry out studies on body accumulation/excretion. It is based on solid-phase extraction (SPE) with size-exclusion liquid chromatography determination. Solid-phase extraction allows the analyte to be retained and subsequently eluted for a clean-up, using a silica-based cartridge. The size-exclusion liquid chromatography of the eluted allows the rest of matrix interferences to be avoided. Fluorescence intensity was measured at λ_em = 350 nm (λ_exc = 300 nm). The sensitivity of the proposed method is in the order of 450 ± 5 mL ng⁻¹ and the detection limit (3 S_y/x/b) in the measured solutions is in the order of 13 ng mL⁻¹, that is 2.6 ng mL⁻¹ in urine samples. The method enables PEG-25 PABA to be determined in both, spiked and unspiked human urine samples. Results obtained for spiked human urine samples (11-100 ng mL⁻¹) demonstrated the accuracy of the method. The mean relative standard deviation of the results was in the order of 3-10%. Three volunteers applied a sunscreen lotion containing a 8% PEG-25 PABA sunscreen cream and their urinary excretion was controlled from the moment of application until the excreted amounts were no longer detectable.     

Determination of the antidepressant paroxetine and its three main metabolites in human plasma by liquid chromatography with fluorescence detection

A high-performance liquid chromatographic method has been developed for the determination in human plasma of the specific serotonin reuptake inhibitor (SSRI) antidepressant paroxetine and its three main metabolites (M1, M2, M3). Fluorescence detection was used, exciting at λ = 294 nm and monitoring emission at λ = 330 nm for paroxetine (λ_exc = 280 nm, λ_em = 330 nm for M1 and M2; λ_exc = 268 nm, λ_em = 290 nm for M3). Separation was obtained on a reversed-phase C18 column using a mobile phase composed of 66.7% aqueous phosphate at pH 2.5 and 33.3% acetonitrile. Imipramine (λ_exc = 252 nm, λ_em = 390 nm) was used as the internal standard. A careful pre-treatment of plasma samples was developed, using solid-phase extraction with C8 cartridges (50 mg, 1 mL). The calibration curves were linear over a working range of 2.5-100 ng mL⁻¹ for paroxetine and of 5-100 ng mL⁻¹ for all metabolites. The limit of detection (LOD) was 1.2 ng mL⁻¹ for PRX and 2.0 ng mL⁻¹ for the metabolites. The method was applied with success to plasma samples from depressed patients undergoing treatment with paroxetine. Hence, the method seems to be suitable for the therapeutic drug monitoring of paroxetine and its main metabolites in depressed patients’ plasma.     

Fluorescence and terbium-sensitised luminescence determination of garenoxacin in human urine and serum

Fluorescence and terbium-sensitised luminescence properties of new quinolone garenoxacin have been studied. The fluorimetric method allows the determination of 0.060-0.600 μg ml⁻¹ of garenoxacin in aqueous solution containing HCl/KCl buffer (pH 1.5) with λ_exc=282 nm and λ_em=421 nm. Micellar-enhanced fluorescence was also studied, leading to a higher than 400% increase in analytical signal in presence of 12 mM sodium dodecyl sulphate (SDS), allowing the determination of 0.020-0.750 μg ml⁻¹ of garenoxacin. The terbium-sensitised luminescence method allows the determination of 0.100-1.500 μg ml⁻¹ of garenoxacin in 12 mM SDS solution containing 0.08 M acetic acid/sodium acetate buffer (pH 4.1) and 7.5 mM Na₂SO₃ (chemical deoxygenation agent), with λ_exc=281 nm and λ_em=546 nm. Relative standard deviation (R.S.D.) values for the three methods were in the range 1.0-2.0%. The proposed procedures have been applied to the determination of garenoxacin in spiked human urine and serum.     

New star-shaped molecules derived from thieno[3,2-b]thiophene unit and triphenylamine

A series of new substituted triphenylamine (TPA) derivatives with alkyl thieno[3,2-b]thiophene and thiophene units were synthesized in a combinatorial manner. Suzuki coupling of a dioxaborolane TPA derivative and 2-bromo-3-nonylthieno[3,2-b]thiophene or Stille coupling of fresh stannyl thieno[3,2-b]thiophene was used. All compounds were characterized by ¹H and ¹³C NMR, HRMS, UV-vis spectrometry and DSC measurements. It was demonstrated that the optical and thermal properties of these materials can be tuned by varying both the conjugation length and thienothiophene and thiophene combination on the TPA branches. Moreover, the measured molar extinction coefficients were increasing from 63,000 (λ_max = 354 nm) to 131,000 L mol⁻¹ cm⁻¹ (λ_max = 428 nm) for TPA-thienothiophenes and TPA-bithiophene thienothiophenes, respectively. Some of them showed molecular glass behavior.     

Normal spectrophotometric and stopped-flow spectrofluorimetric sequential injection methods for the determination of alendronic acid, an anti-osteoporosis amino-bisphosphonate drug, in pharmaceuticals

A normal spectrophotometric and a stopped-flow (SF) spectrofluorimetric method have been developed and optimized for the determination of alendronic acid (ALD) in its pharmaceutical formulations. Both methods are automated using the sequential injection analysis (SIA) principle. The spectrophotometric assay is based on the reaction of the analyte with Cu(II) ions in acidic medium to form an UV-absorbing derivative (λ_max = 240 nm). The SF spectrofluorimetric method is based on the reaction of ALD with o-phthalaldehyde (OPA) in the presence of 2-mercaptoethanol at basic medium (λ_ex = 340 nm/λ_em = 455 nm). Linear calibration curves were obtained in the range 1.0-60.0 mg l⁻¹ ALD for the UV method, and in the range 0.13-10.0 mg l⁻¹ ALD for the SF spectrofluorimetric one. The sampling rates were 60 and 30 h⁻¹, respectively. The developed assays are critically compared and their advantages are discussed. Both methods were applied to the analysis of an ALD containing pharmaceutical formulation with satisfactory accuracy and precision.     

Two different spectrofluorimetric methods for simultaneous determination of gemfibrozil and rosiglitazone in human plasma

Two accurate, reliable, and highly sensitive spectrofluorimetric methods were developed for simultaneous determination of binary mixture gemfibrozil and rosiglitazone in human plasma without prior separation steps. The first method is based on synchronous fluorescence spectrometry using double scans. At Δλ = 27 nm, gemfibrozil yields detectable signal that is independent of the presence of rosiglitazone. Similarly, at Δλ = 120 nm the signal of rosiglitazone is not influenced by the presence of gemfibrozil. Signals at two wavelengths, 301 (Δλ = 27 nm) and 368 nm (Δλ = 120 nm) vary linearly with gemfibrozil and rosiglitazone concentrations over the range 100-700 ng mL⁻¹ (for gemfibrozil) and 20-140 ng mL⁻¹ (for rosiglitazone), respectively. The limits of detection (LOD) were 2.3 and 2.72 ng mL⁻¹ for gemfibrozil and rosiglitazone, respectively. The second method is based on the technique of simultaneous equations (Vierodt's method), in which 258 nm was selected as the excitation wavelength. Two equations are constructed based on the fact that at (λEm₂=302 nm of gemfibrozil) and (λEm₂=369 nm of rosiglitazone) the fluorescence of the mixture is the sum of the individual fluorescence of gemfibrozil and rosiglitazone. The limits of detection (LOD) were 28.1 and 23.63 ng mL⁻¹ for gemfibrozil and rosiglitazone, respectively. The proposed methods were successfully applied for the determination of the two compounds in synthetic mixtures and in human plasma with a good recovery.     

Kinetic spectrophotometric determination of submicromolar orthophosphate by molybdate reduction

A kinetic spectrophotometric procedure was developed for determination of submicromolar orthophosphate based on the reaction in which orthophosphate serves as a catalyst in the reduction of molybdenum, and the initial rate of molybdenum-blue formation (λ_max = 780 nm) is proportional to the concentration of orthophosphate in the samples. The detection limit (3 × standard deviation of blank, n = 8) was 6 nM and the linear calibration ranged from 10 to 100 nM (r² = 0.997). The precisions of this method were 3.3% at 10 nM and 5.4% at 50 nM (n = 8), respectively. Similar to other molybdate based methods, silica and arsenate in the samples can interfere with phosphate determination. The responses of silicate and arsenate were about 25% and 7% of that of orthophosphate, respectively, and their interferences were enhanced in the presence of phosphate in the samples due to the synergistic effect of phosphate with arsenate or silicate on the molybdate reagent.     

Spin trapping of alkoxyl radicals generated from 5-methyl and 5-aryl-3-alkoxy-4-methylthiazole-2(3H)-thiones in photochemically induced and microwave-initiated reactions

Methoxyl and isopropoxyl radicals were generated from N-alkoxy-4,5-dimethylthiazole-2(3H)-thiones (λ_max∼320 nm) and 5-aryl derivatives (aryl=p-XC₆H₄; X=MeO, H, AcNH, Cl) (λ_max∼335 nm) in photochemically and microwave-induced reactions. Alkoxyl radicals were trapped with dimethylpyrrolidine N-oxide and characterized as spin adducts via EPR. Cumyloxyl radicals were liberated in a similar manner from N-cumyloxy-5-(4-methoxyphenyl)-4-methylthiazole-2(3H)-thione. A noteworthy bathochromic shift was found for the lowest energy transition of N-(hydroxy)indeno[2,1-d]thiazole-2(3H)-thione (λ_max=376 nm), if compared to the UV-vis absorption of N-hydroxy-4-methyl-5-phenylthiazole-2(3H)-thione (λ_max=338 nm). Syntheses of alkoxyl radical precursors and procedures for conducting N,O-homolysis are described in a full account.     

Zwitterionic hydrophilic interaction chromatography coupled with post-column derivatization for the analysis of glutathione in wine samples

In this study the development, validation and application of a new chromatographic method for the determination of glutathione (GSH) in wine samples is presented. The separation of the GSH was carried out using a sulfobetaine-based hydrophilic interaction chromatography (HILIC) analytical column whereas its detection was carried out spectrofluorimetrically (λ_ext/λ_em = 340/455 nm) after post-column derivatization with o-phthalaldehyde. GSH was separated efficiently from matrix endogenous compounds of wines by using a mobile phase of 15 mmol L⁻¹ CH₃COONH₄ (pH = 2.5)/CH₃CN, 35/65% (v/v). The parameters of the post-column reaction (pH, amount concentration of the reagent and buffer solution, flow rate, length of the reaction coil) were investigated. The linear determination range for GSH was 0.25–5.0 μmol L⁻¹ and the LOD was 19 nmol L⁻¹. No matrix effect was observed, while the accuracy was evaluated with recovery experiments and was ranged between 89% and 108%.     

Direct observation and kinetic characterization of o-quinodimethane and its radical cation variant generated in a photoinduced electron-transfer reaction of 1,2-bis(α-styryl)benzene

Nanosecond time-resolved absorption spectroscopy on the laser flash photolysis of 1,2-bis(α-styryl)benzene (1) under N-methylquinolinium tetrafluoroborate-toluene-sensitized conditions in acetonitrile confirmed that an o-quinodimethane radical cation (2⁺, λ_max = 569 nm) decayed and the corresponding neutral prototype (2, λ_max = 444 nm) rose with rate constants of 5.6 and 5.9 × 10⁵ s⁻¹, respectively, showing the first agreement in kinetics between a reactive radical cation intermediate intervening in chemical reaction and the corresponding neutral species formed by back electron transfer.     

Development of non-symmetric thiophene-fused BODIPYs

A series of non-symmetric BODIPYs containing thieno[3,2-b]pyrrole moiety were synthesized in 21-63% yields. The absorption and emission maxima covered from the visible green to red region (λ_abs=532-647 nm; λ_em=547-664 nm; Φ_f=0.19-0.45). X-ray analysis indicated that the S-C bond lengths were shorter than those of thienopyrrole and thienohelicene by 0.03-0.05 Å. The crystal packing pattern suggested that strong π-π interaction, intermolecular C-H?F interaction, and weak S?π interaction existed. The tunable emission was achieved by structure modifications. Oxidation of BODIPY (λ_em=547 nm) with m-CPBA generated thiophene-1,1-dioxide derived BODIPY (λ_em=528 nm). Knoevenagel-type condensation of BODIPY with N,N-dimethylaminobenzaldehyde led to BODIPY (λ_em=693 nm) with extended conjugation.     

Optical properties of bis(cyclopentadienyl)magnesium: excimer-type luminescence of the bis(cyclopentadienyl) ligand frame

The electronic spectra of solid MgCp₂ (Cp = cyclopentadienyl) show features which indicate the presence of intramolecular interligand interactions. The fluorescence of MgCp₂ (λ_max = 363 nm) undergoes a considerable Stokes shift which is apparently caused by a bonding attraction between both Cp rings in the excited state. An additional phosphorescence of the (Cp⁻)₂ fragment (λ_max = 535 nm) appears at 77 K.     

Development of a rapid and automatic optosensor for the determination of cromolyn in biological samples

Disodium cromoglycate (SCG) is an anti-allergic drug, which is applied locally or inhaled. After administration, a very small portion of the drug is absorbed, being the most eliminated part unchanged in the urine and bile; therefore, its determination in urine is indicative of the dose absorbed. Here, the first spectroscopic method for the determination of SCG, making use of a sequential injection optosensor with terbium-sensitized luminescence detection, is described. The cationic resin Chelex-100 was used as solid support in the detection area. The measurements were made at 336/545 nm (λ_ex/λ_em) and the system was calibrated for two sample volumes, 150 and 800 μl, depending on the samples analyzed. A detection limit of 15 ng ml⁻¹ and a RSD lower than 2% (n = 10) were observed using the highest sample volume. The proposed method does not use any organic solvent or surfactant, so being environmental friendly. The analyte was satisfactorily determined in pharmaceuticals and human urine, the latter being spiked at the concentrations found after the administration of the drug.     

Zygosporamide, a cytotoxic cyclic depsipeptide from the marine-derived fungus Zygosporium masonii

Zygosporamide (1), a new cyclic pentadepsipeptide, was isolated from the seawater-based fermentation broth of a marine-derived fungus identified as Zygosporium masonii. The structure of 1, which is composed of α-hydroxyleucic acid and both d- and l-amino acids, was determined by combined spectral and chemical methods. Despite a simple structure, zygosporamide illustrated significant cytotoxicity in the NCI’s 60 cell line panel (median GI₅₀ = 9.1 μM), with highly enhanced selectivity against the CNS cancer cell line SF-268 (GI₅₀ = 6.5 nM) and the renal cancer cell line RXF 393 (GI₅₀ ? 5.0 nM).     

Study on spectroscopic characterization of Pd porphyrin and its interaction with ctDNA

The fluorescence and solid substrate room temperature phosphorescence (SS-RTP) properties of Pd(II) meso-tetrakis (4-N-methyl-pyridiniumyl) porphyrin (Pd(II)TMPyP) were studied. The factors influencing the SS-RTP emission, such as filter type, inorganic salt sort, drying temperature, pre-drying time and drying time were investigated in detail. Strong SS-RTP signal can be induced on the slow speed filter paper in the presence of the external inorganic salt, Ca(NO₃)₂, with the maximum excitation and emission wavelengths at 421 nm and 675 nm, respectively. The interaction between calf thymus DNA (ctDNA) and Pd(II)TMPyP was investigated at pH 7.2 using SS-RTP, fluorescence and UV-vis spectroscopy. The SS-RTP intensity of Pd(II)TMPyP was enhanced efficiently with the increasing amount of ctDNA. This phenomenon demonstrates that the intercalated porphyrin is shielded by ctDNA to avoid collision quenching. This result was supported by SS-RTP lifetime measurement, SS-RTP anion quenching experiment and fluorescence polarization measurement. Furthermore, with the addition of ctDNA, the UV-vis spectra of Pd(II)TMPyP shows apparent hypochromicity (40%) at the Soret maximum of 417 nm and a red shift of Δλ = 15 nm, also indicating that Pd(II)TMPyP intercalates into ctDNA bases. The binding constant of Pd(II)TMPyP to ctDNA was calculated to be 4.41 × 10⁵ L/mol based on the derivative McGhee-von Hippel plots.     

Fluorimetric determination of aminocaproic acid in pharmaceutical formulations using a sequential injection analysis system

A sequential injection analysis (SIA) methodology for the fluorimetric determination of aminocaproic acid in pharmaceutical formulations is proposed. The developed analytical procedure is based on the derivatisation reaction of the aminocaproic primary amine with o-phthalaldehyde (OPA) and N-acetylcysteine (NAC) and fluorimetric detection of the formed product (λ_ex = 350 nm; λ_em = 450 nm). The implementation of a SIA flow system allowed for the development of a simple, fast and versatile automated methodology, which exhibits evident advantages regarding the US Pharmacopoeia 24 (USP 24) reference procedure. By combining the SIA time-based sample insertion with a subsequent zone sampling approach, which permitted to select for detection of a well-defined sample zone, it was possible to implement an on-line dilution strategy that enabled the expansion of the analytical working range of the methodology, and thus its application in dissolution studies, without manifold re-configuration.Linear calibration plots were obtained for aminocaproic acid concentrations up to 6 × 10⁻⁵ mol l⁻¹. The developed methodology exhibit a good precision, with a R.S.D. < 2.0% (n = 15) and the detection limit was 2.5 × 10⁻⁷ mol l⁻¹. The obtained results complied with those furnished by the reference procedure with a relative deviation lower than 1.2%. No interference was found.     

Determination of Cinchona alkaloids and Vitamin B6 by high-performance liquid chromatography with fluorescence detection

A simple and specific method has been developed for the simultaneous determination of the four major Cinchona alkaloids and their dihydroderivatives and pyridoxine hydrochloride (Vitamin B₆) by high-performance liquid chromatography (HPLC) with fluorescence detection (λ_em=420 nm with λ_ex=330 nm). The chromatographic separation was performed on a Phenomenex Prodigy ODS column (5 μm,  mm i.d.), recommended for basic compounds, under isocratic reversed-phase conditions. The method allowed a good peak shape and an effective resolution of the tested compounds. The extraction of alkaloids from the Cinchona succirubra bark was carried out in mild and fast conditions (ambient temperature, 20 min) by ultrasonication. The procedure showed to be advantageous respect to a reference method, which involved Soxhlet extraction. The results were compared statistically by means of the Student’s t-test and the variance ratio F-test; no significant difference was found. The method was reproducible (relative standard deviations in the range of 1.0-5.0% for the different alkaloids) and gave quantitative recovery of alkaloids added to bark samples (97.8-105%). For additional informations a photoreactor was arranged between the analytical column and the detector and the online post-column photochemical conversion (irradiation=254 nm) was investigated. Vitamin B₆ was shown to be highly photosensitive, giving significantly different fluorescence spectra with and without UV irradiation. The proposed method was successfully applied to the quality control of Cinchona bark, liquid extract and cosmetics.     

Analysis of salicylic acid based on the fluorescence enhancement of the As(III)-salicylic acid system

A new, simple and sensitive spectrofluorimetric method for the determination of salicylic acid (λ_ex = 315 nm, λ_em = 408 nm) using As(III) as a sensitizing reagent has been investigated by measuring the increase of fluorescence intensity of salicylic acid due to the complexation of As(III)-salicylic acid in presence of sodium dodecyl sulfate (SDS) 10⁻³ M. Under optimum conditions, a significant relationship was obtained between the fluorescence intensity and salicylic acid concentration. A linear calibration curve was obtained in the range 13.8-13812 μg l⁻¹ with product-moment correlation coefficient (R) 0.99985 and detection limit 4.2 μg l⁻¹. The R.S.D. is 2.35% (n = 5).The method was applied successfully to the determination of salicylic acid in human serum.     

Spatially selected synthesis of LaF3 and Er-doped CaF2 crystals in oxyfluoride glasses by laser-induced crystallization

Oxyfluoride glasses with a small amount of NiO are prepared using a conventional melt quenching technique, and the spatially selected crystallization of LaF₃ and CaF₂ crystals is induced on the glass surface by irradiations of continuous wave lasers with a wavelength of λ=1064 or 1080 nm. Dots and lines including LaF₃ crystals are patterned by heat-assisted (300 °C) laser irradiations (λ=1064 nm) with a power of P=1 W and an irradiation time of 10 s for dots and a scanning speed of S=5 μm/s for lines. Lines consisting of CaF₂ crystals are also patterned in an ErF₃-doped oxyfluoride glass by laser irradiations (λ=1080 nm) with a power of P=1.7 W and a scanning speed of S=2 μm/s, and the incorporation of Er³⁺ ions into CaF₂ crystals is confirmed from micro-photoluminescence spectrum measurements. It is proposed that the lines patterned by laser irradiations in this study are consisted of the composite of LaF₃ or CaF₂ nanocrystals and SiO₂-based oxide glassy phase. It is demonstrated that a combination of Ni²⁺-dopings and laser irradiations is effective in spatially selected local crystallizations of fluorides in oxyfluoride glasses.     

A novel application of immobilization on membranes for the separation and spectrofluorimetric quantification of amiloride and furosemide in pharmaceutical samples

A new, simple and highly sensitive method for spectrofluorimetric determination of amiloride (AMI) and furosemide (FUR) in pharmaceuticals is presented. The proposed method is based on the separation of AMI from FUR by solid-phase extraction using a nylon membrane, followed by spectrofluorimetric determination of both drugs, on the solid surface and the filtered aqueous solution, respectively. AMI shows low native fluorescence, but its separation-preconcentration by immobilization (solid-phase extraction) on nylon membrane surface provides a considerable enhancement in fluorescence intensity. The fluorescence determination is carried out at λ_ex = 237, λ_em = 415 nm for FUR; and λ_ex = 365, λ_em = 406 nm for AMI. The calibration graphs are linear in the range 3.20 × 10⁻⁴ to 0.8 μg mL⁻¹and 1.33 × 10⁻³ to 4.0 μg mL⁻¹, for AMI and FUR, respectively, with a detection limit of 9.62 × 10⁻⁵ and 4.01 × 10⁻⁴ μg mL⁻¹ (S/N = 3). The commonly found excipients in commercial pharmaceutical formulations do not interfere. The developed method is successfully applied to the determination of both drugs in pharmaceutical formulations.